Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Skin bacteria can help wound healing by activating certain immune cells.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

γδ T cells are essential for wound healing after poxvirus infection.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Clonally expanded CD8+ T cells cause alopecia areata.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.